Gated SPECT myocardial perfusion scintigraphy: A multi-faceted tool for the evaluation of heart failure

Journal of Nuclear Cardiology

Volumn 16, Issue 2, 2009, Pages 173-175

  Soman, Prem ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NITRITE; TECHNETIUM 99M;

CLINICAL TRIAL; COHORT ANALYSIS; CONTRAST ENHANCEMENT; DISEASE SEVERITY; EDITORIAL; ELECTROCARDIOGRAPHY; EXERCISE TEST; GATED IMAGING; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE VOLUME; HEART MUSCLE PERFUSION; HUMAN; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ANALYSIS; RELIABILITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; METHODOLOGY; NOTE; SCINTISCANNING;

CARDIAC-GATED SINGLE-PHOTON EMISSION COMPUTER-ASSISTED TOMOGRAPHY; HEART FAILURE; HUMANS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 67649960497     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12350-009-9050-8     Document Type: Editorial

References (14)

1. Ragosta M, Beller GA, Watson DD, Kaul S, Gimple LW. Quantitative planar rest-redistribution 201Tl imaging in detection of myocardial viability and prediction of improvement in left ventricular function after coronary bypass surgery in patients with severely depressed left ventricular function. Circulation 1993;87:1630-41.
2. Bisi G, Sciagra R, Santoro GM, Fazzini PF. Rest technetium-99m sestamibi tomography in combination with short-term administration of nitrates: Feasibility and reliability for prediction of postrevascularization outcome of asynergic territories. J Am Coll Cardiol 1994;24:1282-9.
3. Klocke FJ, Baird MG, Lorell BH, Bateman TM, Messer JV, Berman DS, et al. ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging-executive summary: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 guidelines for the clinical use of cardiac radionuclide imaging). Circulation 2003;108:1404-18.
4. Gheorghiade M, Sopko G, De Luca L, Velazquez EJ, Parker JD, Binkley PF, et al. Navigating the crossroads of coronary artery disease and heart failure. Circulation 2006;114:1202-13.
5. Felker GM, Shaw LK, O'Connor CM. A standardized definition of ischemic cardiomyopathy for use in clinical research. J Am Coll Cardiol 2002;39:210-8.
6. Soman P, Lahiri A, Mieres JH, Calnon DA, Wolinsky D, Beller GA, Sias T, Burnham KM, Conway L, McCullough P, Daher E, Walsh MN, Wight J, Heller GV, Udelson JE. Etiology and pathophysiology of new-onset heart failure: Evaluation by myocardial perfusion imaging. J Nucl Cardiol 2009;16:82-91.
7. Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: A meta-analysis. J Am Coll Cardiol 2002;39:1151-8.
8. Senior R, Lahiri A, Kaul S. Effect of revascularization on left ventricular remodeling in patients with heart failure from severe chronic ischemic left ventricular dysfunction. Am J Cardiol 2001;88:624-9.
9. Chen J, Henneman MM, Trimble MA, Bax JJ, Borges-Neto S, Iskandrian AE, et al. Assessment of left ventricular mechanical dyssynchrony by phase analysis of ECG-gated SPECT myocardial perfusion imaging. J Nucl Cardiol 2008;15:127-36.
10. Henneman MM, Chen J, Dibbets-Schneider P, Stokkel MP, Bleeker GB, Ypenburg C, et al. Can LV dyssynchrony as assessed with phase analysis on gated myocardial perfusion SPECT predict response to CRT? J Nucl Med 2007;48:1104-11.
11. Chung ES, Leon AR, Tavazzi L, Sun JP, Nihoyannopoulos P, Merlino J, et al. Results of the predictors of response to CRT (PROSPECT) trial. Circulation 2008;117:2608-16.
12. Douglas PS, Morrow R, Ioli A, Reichek N. Left ventricular shape, afterload and survival in idiopathic dilated cardiomyopathy. J Am Coll Cardiol 1989;13:311-5.
13. Abidov A, Slomka PJ, Nishina H, Hayes SW, Kang X, Yoda S, et al. Left ventricular shape index assessed by gated stress myocardial perfusion SPECT: Initial description of a new variable. J Nucl Cardiol 2006;13:652-9.
14. Fukuchi K, Yasumura Y, Kiso K, Hayashida K, Miyatake K, Ishida Y. Gated myocardial SPECT to predict response to beta-blocker therapy in patients with idiopathic dilated cardiomyopathy. J Nucl Med 2004;45:527-31.